Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challenges
Although atopic dermatitis (AD) is primarily a Th2-driven disease, it shows high heterogeneity with additional variable contributions of the Th22, Th17, and Th1 pathways, depending on the subtype of the disease. Expanding knowledge and understanding of AD pathogenesis has promoted the development of...
Saved in:
Published in | Archives of pharmacal research Vol. 45; no. 12; pp. 894 - 908 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Seoul
Pharmaceutical Society of Korea
01.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!